How the proposed $7.3B Roundup class action could cap attorney fees at 22% for cases signed after February 17, 2026

Why resolving future, undiagnosed Roundup claims may be a strategic win for defendants

What Zuckerberg’s testimony revealed and how his courtroom performance may influence jurors

How Meta’s 2018 internal communications on addiction risk strengthen the plaintiffs’ narrative

Why J&J’s effort to sideline Beasley Allen reflects a broader defense strategy in legacy mass torts

What the upcoming Bair Hugger trial in Texas means for applying pressure on 3M